Renaissance Technologies - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 55 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$773,000
+8488.9%
822,655
+4708.3%
0.00%
Q2 2020$9,000
-91.7%
17,109
-56.0%
0.00%
Q2 2016$109,000
-38.4%
38,907
+34.6%
0.00%
Q1 2016$177,000
+124.1%
28,900
+97.9%
0.00%
Q4 2015$79,00014,6000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Greenlight Capital 292,366$283,0000.02%
Virtu Financial LLC 204,870$199,0000.02%
Verdence Capital Advisors LLC 143,382$139,0000.02%
Founders Capital Management 18,000$17,0000.01%
WOLFF WIESE MAGANA LLC 10,740$10,0000.01%
Global Strategic Investment Solutions, LLC 23,000$22,0000.00%
Belvedere Trading LLC 118,500$146,0000.00%
Affinity Capital Advisors, LLC 13,180$13,0000.00%
Atom Investors LP 56,492$55,0000.00%
Stonebridge Capital Advisors LLC 22,000$21,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders